Log in

Relevant bibliographies by topics / NET / Journal articles

To see the other types of publications on this topic, follow the link: NET.

Journal articles on the topic 'NET'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'NET.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sabrin, F., M. A. Uddin, and A. K. F. Haque. "Applicability of Vaisburd and Evdokimov Model to Ionic Targets." Journal of Scientific Research 4, no. 2 (2012): 307. http://dx.doi.org/10.3329/jsr.v4i2.8704.

Full text

Abstract:

The Vaisburd and Evdokimov proposed an empirical model to calculate the electron impact single ionization cross-sections of atoms and molecules. The model has been applied to some atoms and molecules. To examine the efficiency of the model, the present work applies the model to calculate cross-sections for Ne-isonuclear series Ne+, Ne2+, Ne3+, Ne4+, Ne5+, Ne6+, Ne7+, Ne8+, Ne9+ . The separate sets of values of the parameters of the model are determined by comparison with the available experimental data using a non-linear least-squares fitting computer code. Keywords: Electron impact ionization

APA, Harvard, Vancouver, ISO, and other styles

2

Abduloeva, N. K., V. M. Moiseenko, F. V. Moiseenko, O. A. Skripko, M. V. Scriabin, and R. A. Ryanjina. "Long-term outcomes of neoadjuvant endocrine therapy versus chemotherapy in luminal HER2-breast cancer." Practical oncology 25, no. 1 (2024): 41–48. http://dx.doi.org/10.31917/2501041.

Full text

Abstract:

Introduction. Neoadjuvant endocrine therapy (NET) is an effective treatment modality that can downsize breast tumors in a cohort of postmenopausal women with HR-positive HER2-negative breast cancer. A lack of data regarding efficacy of NET vs neoadjuvant cytotoxic chemotherapy (NCT) leads to limited usage of NET despite its favorable toxicity profile. Perioperative endocrine therapy is mainly used for the elderly or patients with comorbidities that limit their access to NCT. The COVID-19 pandemic led to increased data of NET efficacy. Nevertheless, long-term outcomes of NET application are und

APA, Harvard, Vancouver, ISO, and other styles

3

Kinoshita, S. "Kyoshin Net (K-NET)." Seismological Research Letters 69, no. 4 (1998): 309–32. http://dx.doi.org/10.1785/gssrl.69.4.309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kramarae, Cheris, and Jana Kramer. "Net Gains, Net Losses." Women's Review of Books 12, no. 5 (1995): 33. http://dx.doi.org/10.2307/4021979.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Grover, Jan Zita, Paulina Borsook, Susan Hawthorne, and Renate Klein. "Bad Net, Good Net." Women's Review of Books 17, no. 12 (2000): 12. http://dx.doi.org/10.2307/4023550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Endo, Shunji, Tsutomu Dousei, Yukinobu Yoshikawa, et al. "Gastric Neuroendocrine Tumors in Our Institutions According to the WHO 2010 Classification." International Surgery 97, no. 4 (2013): 335–39. http://dx.doi.org/10.9738/cc134.1.

Full text

Abstract:

Abstract In 2010, World Health Organization classified gastric neuroendocrine tumor (NET) as follows: NET grade (G) 1, NET G2, neuroendocrine carcinoma (NEC). We reviewed 22 gastric NETs that were encountered in our institutions. Nine, 6, and 4 were NET G1, G2, and NEC, respectively. We also encountered 3 NET G3. NET G1 was treated with observation in 2 patients, endoscopic mucosal resection (EMR) in 3, and gastrectomy in 4 patients. No recurrence was experienced during a median of 53 months of follow-up. All NET G2 was treated with gastrectomy. No patient experienced recurrence during a media

APA, Harvard, Vancouver, ISO, and other styles

7

Heetfeld, M., C. N. Chougnet, I. H. Olsen, et al. "Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms." Endocrine-Related Cancer 22, no. 4 (2015): 657–64. http://dx.doi.org/10.1530/erc-15-0119.

Full text

Abstract:

Data on gastroenteropancreatic neuroendocrine neoplasms (NEN) G3 (well-differentiated neuroendocrine tumors (NET G3) and neuroendocrine carcinoma (NEC)) are limited. We retrospectively study patients with NET G3 and NEC from eight European centers. Data examined included clinical and pathological characteristics at diagnosis, therapies and outcomes. Two hundred and four patients were analyzed (37 NET G3 and 167 NEC). Median age was 64 (21–89) years. Tumor origin included pancreas (32%) and colon-rectum (27%). The primary tumor was resected in 82 (40%) patients. Metastatic disease was evident a

APA, Harvard, Vancouver, ISO, and other styles

8

Berghel, Hal. "Net Neutrality vs. Net Neutering." Computer 49, no. 3 (2016): 73–77. http://dx.doi.org/10.1109/mc.2016.84.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Blaxter, J. H. S. "Net profit or net loss?" Nature 371, no. 6497 (1994): 483. http://dx.doi.org/10.1038/371483a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Zou, Jinghan, Shuhui Yin, Mingxing Guo, et al. "Isotopic Effect on Stereodynamics of the Reactions H + NeH+/H + NeD+/H + NeT+." Bulletin of the Chemical Society of Japan 86, no. 4 (2013): 472–78. http://dx.doi.org/10.1246/bcsj.20120109.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Busse, Antonia, Liliana H. Mochmann, Christiane Spenke, et al. "Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment." Cancers 12, no. 11 (2020): 3448. http://dx.doi.org/10.3390/cancers12113448.

Full text

Abstract:

Checkpoint inhibitors have shown promising results in a variety of tumors; however, in neuroendocrine tumors (NET) and neuroendocrine carcinomas (NEC), low response rates were reported. We aimed herein to investigate the tumor immune microenvironment in NET/NEC to determine whether checkpoint pathways like programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) might play a role in immune escape and whether other escape mechanisms might need to be targeted to enable a functional antitumor response. Forty-eight NET and thirty NEC samples were analyzed by immunohistochemistry (I

APA, Harvard, Vancouver, ISO, and other styles

12

Basnet, Alina, Dongliang Wang, and Abirami Sivapiragasam. "Utilization, trend and impact of neoadjuvant endocrine therapy compared to neoadjuvant chemotherapy in postmenopausal breast cancer patients: Analysis of the National Cancer Data Base." Journal of Clinical Oncology 35, no. 15_suppl (2017): 578. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.578.

Full text

Abstract:

578 Background: Three small prospective trials that compared the efficacy of neoadjuvant endocrine therapy (NET) to neoadjuvant chemotherapy (NCT) showed no statistically significant difference. We report the differences in utilization of NET and NCT using National Cancer Data Base (NCDB) and their trend, response rates (RR) and breast conservation rates (BCR). Methods: A retrospective review of hormone receptor positive breast cancer patients ≥ 50 yrs without metastasis using NCDB was performed (2004-2014). Patients underwent NET or NCT prior to definitive surgery. Utilization pattern, practi

APA, Harvard, Vancouver, ISO, and other styles

13

Hueser, Sophia A., Reese E. Townsend, Casandro J. Chan, et al. "Abstract 4000: The significance of GLP-1R and its agonist in neuroendocrine neoplasms." Cancer Research 85, no. 8_Supplement_1 (2025): 4000. https://doi.org/10.1158/1538-7445.am2025-4000.

Full text

Abstract:

Abstract Neuroendocrine neoplasms (NENs) are rare cancers originating from neuroendocrine cells that are found throughout the body. NENs are subdivided into 2 categories: Well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas (NEC). Both NET and NEC are highly metastatic and difficult to treat. NEN cases are on the rise and yet the etiology remains unclear. Commonly used drugs such as proton pump inhibitors can promote NET growth and result in poor prognosis for NET patients. Nowadays, the diabetes and weight loss drug semaglutide, a glucagon-like p

APA, Harvard, Vancouver, ISO, and other styles

14

Shiba, Satoshi, Chigusa Morizane, Shunsuke Kondo, et al. "Pancreatic neuroendocrine tumors: Twenty years’ experience of 100 patients at a single center." Journal of Clinical Oncology 30, no. 4_suppl (2012): 179. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.179.

Full text

Abstract:

179 Background: Pancreatic neuroendocrine tumors (NETs) are rare neoplasms that exhibit a variety of diverse morphological, functional and behavioral characteristics. However, only a few reports have evaluated large case series of pancreatic endocrine tumors. Methods: We conducted a retrospective review of 100 consecutive patients with pancreatic NETs diagnosed pathologically and treated at the National Cancer Center Hospital between 1991 and 2010. Results: The characteristics of the 100 patients were as follows: male, 49; female, 51; median age, 55 years. Fourteen patients gave a history of e

APA, Harvard, Vancouver, ISO, and other styles

15

Seth, H. ".Net." Computer Bulletin 44, no. 1 (2002): 32. http://dx.doi.org/10.1093/combul/44.1.32.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Madoff, David. "NET." Journal of Vascular and Interventional Radiology 16, no. 2 (2005): P18. http://dx.doi.org/10.1016/s1051-0443(05)70031-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jablonska, Jadwiga. "To NET or not to NET." American Journal of Immunology 10, no. 4 (2014): 174–75. http://dx.doi.org/10.3844/ajisp.2014.174.175.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

V, Slyusar. "Inverse Architecture U-Net – InvU-Net." Artificial Intelligence 29, AI.2024.29(4) (2024): 115–32. https://doi.org/10.15407/jai2024.04.115.

Full text

Abstract:

The article proposes an inverse architecture of the U-Net neural network, named InvU-Net, which differs from the traditional scheme by increasing the dimensionality of images during the initial stages of processing. A comparison was conducted between two approaches for increasing image resolution: UpSampling2D layers and transposed Conv2DTranspose convolutional layers. The latter demonstrated superior results due to its ability to learn weighting coefficients. As part of the study, several InvU-Net modifications were developed and tested: Small, Medium, and Large, differing in structural compl

APA, Harvard, Vancouver, ISO, and other styles

19

Rokach, Joshua Z. "Net Metering Needs a Safety Net." Electricity Journal 24, no. 9 (2011): 106–8. http://dx.doi.org/10.1016/j.tej.2011.09.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Peters, R. "NET TIP:Job Hunting with a Net." Science 281, no. 5375 (1998): 366–67. http://dx.doi.org/10.1126/science.281.5375.366.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Schwartau, Winn. "To net or not to net?" Network Security 1994, no. 12 (1994): 7–11. http://dx.doi.org/10.1016/1353-4858(94)90024-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Adnan, Shah Ali, and Akanksha . "Net Zero/Net Zero Carbon Emission." ADHYAYAN: A JOURNAL OF MANAGEMENT SCIENCES 12, no. 02 (2023): 1–5. http://dx.doi.org/10.21567/adhyayan.v12i2.01.

Full text

Abstract:

Every other day we hear about environmental and climate issues and the effect of global warming or carbon emission. Many companies are shifting their concerns from making profits to making sustainable profits. The idea of saving the environment has propelled many start-ups also. Organizations worldwide are concerned about the consequences of wasting natural resources and trying their best to find a solution as soon as possible. The Paris Agreement and the Net Zero Coalition are some of the treaties the UN organization is trying to implement. The problem is that some people are ignoring climate

APA, Harvard, Vancouver, ISO, and other styles

23

Basnet, Alina, Dongliang Wang, and Abirami Sivapiragasam. "Survival advantage associated with neoadjuvant chemotherapy compared to neoadjuvant hormonal therapy in postmenopausal women with hormone receptor positive breast cancer: A National Cancer Data Base study." Journal of Clinical Oncology 35, no. 15_suppl (2017): e12119-e12119. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12119.

Full text

Abstract:

e12119 Background: Neoadjuvant endocrine therapy (NET) and neoadjuvant chemotherapy (NCT) are both considered effective strategies in postmenopausal, hormone receptor positive breast cancer patients. Small prospective studies show comparable response rates and breast conservation rates. Using National Cancer Data Base (NCDB) we report overall survival (OS) differences between these two strategies with subgroup analysis by Estrogen Receptor (ER), Progesterone Receptor (PgR) status. Methods: We extracted data on hormone receptor positive breast cancer patients without metastasis in women aged ≥

APA, Harvard, Vancouver, ISO, and other styles

24

Shibuki, Taro, Hiroyuki Okuyama, Naohiro Okano, et al. "Multicenter, retrospective, observational study of outcomes of treatment for unresectable neuroendocrine tumors G3 of gastroenteropancreatic or unknown primary origin." Journal of Clinical Oncology 43, no. 4_suppl (2025): 660. https://doi.org/10.1200/jco.2025.43.4_suppl.660.

Full text

Abstract:

660 Background: The 2017 edition of the WHO classification categorized neuroendocrine neoplasms (NEN) as neuroendocrine tumors (NET) G1, G2, G3, and neuroendocrine carcinoma (NEC). Prior to 2017, NET G3 was categorized as NEC in the WHO 2010 classification. Platinum-based chemotherapy, commonly used as first-line treatment for these tumors, shows suboptimal efficacy for NET G3. Additionally, large-scale studies and robust evidence on chemotherapy outcomes for NET G3 are lacking. We investigated chemotherapy regimens for NET G3 and evaluated their outcomes. Methods: We included 73 patients (pts

APA, Harvard, Vancouver, ISO, and other styles

25

gu, chongshan, yingjian he, jinfeng li, tianfeng wang, zhaoqing Fan, and tao ouyang. "Abstract P5-09-04: Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with hormone-responsive and HER2-negative, lymph node-negative breast cancer." Cancer Research 83, no. 5_Supplement (2023): P5–09–04—P5–09–04. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-09-04.

Full text

Abstract:

Abstract Background: Neoadjuvant endocrine therapy (NET) has demonstrated efficacy in post-menopausal patients with hormone-responsive and her2-negative breast cancer. This trial was designed to compare the efficacy of neoadjuvant chemotherapy (NCT) with NET in pre-menopausal patients with hormone-responsive, her2-negative and lymph node-negative breast cancer. Materials and Methods: In this prospective, randomised study, pre-menopausal patients with hormone-responsive, her2-negative and lymph node-negative breast cancer were recruited. Enrolled patients were randomly assigned (1:1) to receive

APA, Harvard, Vancouver, ISO, and other styles

26

Orlova, Rashida, Almira Vakhitova, Mark Gluzman, et al. "Results of the prospective randomized controlled trial VOG-01: Neoadjuvant endocrine therapy ribociclib + fulvestrant + GnRH-a versus chemotherapy 4 AC + 4 T for early HR+/HER2-negative breast cancer in premenopausal patients." Journal of Clinical Oncology 43, no. 16_suppl (2025): 606. https://doi.org/10.1200/jco.2025.43.16_suppl.606.

Full text

Abstract:

606 Background: CDK4/6 inhibitors are used to treat HR+/HER2- metastatic breast cancer in combination with endocrine therapy. However, there is still a lack of evidence about combined endocrine therapy in neoadjuvant setting. VOG-01 is a phase II randomized trial that evaluated the effects of combination ribociclib plus fulvestrant and GnRH-a as neoadjuvant therapy in premenopausal patients. Methods: Premenopausal women with HR+/HER2-negative stage II-III were randomly assigned to Fulvestrant (500 mg on the 1st, 15th, 28th days of the first cycle, then once every 28 days), Triptorelin (3.75 mg

APA, Harvard, Vancouver, ISO, and other styles

27

Okada, Yoshimitsu, Keiji Kasahara, Sadaki Hori, et al. "Recent progress of seismic observation networks in Japan —Hi-net, F-net, K-NET and KiK-net—." Earth, Planets and Space 56, no. 8 (2004): xv—xxviii. http://dx.doi.org/10.1186/bf03353076.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Jeon, Young Kyung, Ji-Yeon Kim, Jin Seok Ahn, et al. "Abstract P3-05-07: Primary neuroendocrine carcinoma of the breast: A case series by WHO classfication in 2019." Cancer Research 83, no. 5_Supplement (2023): P3–05–07—P3–05–07. http://dx.doi.org/10.1158/1538-7445.sabcs22-p3-05-07.

Full text

Abstract:

Abstract Introduction Neuroendocrine tumours (NET) are thought to arise from cells throughout the diffuse endocrine system and can occur almost everywhere in the body. Most NETs arise from the gastrointestinal tract, lung, thymus, and pancreas. Primary neuroendocrine carcinoma (NEC) of the breast is a rare and under-recognized subtype, accounting for less than 1% of breast carcinomas. Only a few small studies and case reports have been reported and there are no clear diagnostic criteria and established treatment options. World Health Organization (WHO) classification of tumor series’ fifth edi

APA, Harvard, Vancouver, ISO, and other styles

29

Cho, Hyung-Gyo, Wonkyung Jung, Soo Ick Cho, et al. "Artificial intelligence-powered whole-slide image analyzer reveals a distinctive distribution of tumor-infiltrating lymphocytes in neuroendocrine tumors and carcinomas." Journal of Clinical Oncology 40, no. 16_suppl (2022): e16214-e16214. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16214.

Full text

Abstract:

e16214 Background: Immune checkpoint inhibitors (ICIs) have shown promising treatment outcomes for various types of tumors. However, in neuroendocrine tumors and carcinomas (NET/NEC), ICI has proven to be applicable for only limited cases. In addition, little is known about the immunoprofile of NET/NEC. Here we investigate the landscape of tumor-infiltrating lymphocytes (TIL) using artificial intelligence (AI)-powered H&E whole-slide image (WSI) analyzer to elucidate the tumor microenvironment of NET/NEC. Methods: A total of 240 H&E stained pathologic slides diagnosed with NET/NEC were

APA, Harvard, Vancouver, ISO, and other styles

30

Dodson, Thomas B. "When Net Loss Threatens Safety Net Loss." Journal of Oral and Maxillofacial Surgery 76, no. 12 (2018): 2459–60. http://dx.doi.org/10.1016/j.joms.2018.09.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Mateosian, R. "Microsoft's .NET platform introducing .NET [Book Reviews]." IEEE Micro 21, no. 2 (2001): 94–95. http://dx.doi.org/10.1109/mm.2001.918030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Boeve, M. N. (Marlon). "‘No net land take’ of net niks?" Tijdschrift voor Omgevingsrecht 23, no. 1 (2023): 3–4. http://dx.doi.org/10.5553/to/156850122023023001002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Scoazec, Jean-Yves, Anne Couvelard, Genevieve Monges, et al. "Well-differentiated grade 3 digestive neuroendocrine tumors: Myth or reality? The PRONET study group." Journal of Clinical Oncology 30, no. 15_suppl (2012): 4129. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4129.

Full text

Abstract:

4129 Background: In contrast to the 2000 World Health Organization (WHO) classification of digestive neuroendocrine tumors (NET) in which morphologic differentiation was the first criterion, the 2010 WHO classification of NET is based mostly on histologic grade. NET are now classified into three main categories: NET G1 (mitotic count <2/10 HPF and/or ≤2% Ki67 index), NET G2 (2-20/10 HPF and/or 3-20%), and neuroendocrine carcinoma (NEC) of small or large cell type. While NET G1 and G2 are well-differentiated tumors, NEC are considered poorly differentiated G3 tumors. We looked at the agreeme

APA, Harvard, Vancouver, ISO, and other styles

34

Turk, Fuat, and Mahmut Kılıçaslan. "Lung image segmentation with improved U-Net, V-Net and Seg-Net techniques." PeerJ Computer Science 11 (February 13, 2025): e2700. https://doi.org/10.7717/peerj-cs.2700.

Full text

Abstract:

Tuberculosis remains a significant health challenge worldwide, affecting a large population. Therefore, accurate diagnosis of this disease is a critical issue. With advancements in computer systems, imaging devices, and rapid progress in machine learning, tuberculosis diagnosis is being increasingly performed through image analysis. This study proposes three segmentation models based on U-Net, V-Net, and Seg-Net architectures to improve tuberculosis detection using the Shenzhen and Montgomery databases. These deep learning-based methods aim to enhance segmentation accuracy by employing advance

APA, Harvard, Vancouver, ISO, and other styles

35

Taherian, Mehran, Shabnam Samankan, Adrienne Groman, Saikrishna S. Yendamuri, and Amarpreet Bhalla. "Comparison of tumor characteristics and survival between esophageal and other gastroenteropancreatic neuroendocrine neoplasms." Journal of Clinical Oncology 37, no. 15_suppl (2019): e15556-e15556. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15556.

Full text

Abstract:

e15556 Background: Neuroendocrine neoplasms (NEN) of esophagus are extremely rare. Limited information is available on survival of these tumors. The objective of this study was to define the clinicopathologic predictors of overall survival (OS) in esophageal NEN, and to compare them with the other gastroenteropancreatic NEN (GEP-NEN). Methods: Esophageal NEN were selected from the National Cancer Database (2004–2013). Multivariable analysis and Kaplan–Meier method were performed. The prognostic factors for GEP-NEN were derived from literature including WHO classification and AJCC TNM classific

APA, Harvard, Vancouver, ISO, and other styles

36

Farmer, Jane, and Amanda Richardson. "Net profit." Nursing Standard 12, no. 17 (1998): 28–31. http://dx.doi.org/10.7748/ns.12.17.28.s46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Cookson, Amelia. "Net gains." Nursing Older People 21, no. 1 (2009): 6–7. http://dx.doi.org/10.7748/nop.21.1.6.s9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Anthony, Denis. "Net profits." Nursing Standard 20, no. 3 (2005): 38–39. http://dx.doi.org/10.7748/ns.20.3.38.s63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hise, Thomas L., Robert G. Chester, and Charlotte Omoto. "Net Pluses." Science News 157, no. 16 (2000): 243. http://dx.doi.org/10.2307/4012481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Botia Paniagua, Enrique, and Santiago Mola Caballero de Rodas. "Neurologia@net." Revista de Neurología 26, no. 151 (1998): 497. http://dx.doi.org/10.33588/rn.26151.98232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Botia Paniagua, Enrique, and Santiago Mola Caballero de Rodas. "Neurologia@net." Revista de Neurología 26, no. 152 (1998): 672. http://dx.doi.org/10.33588/rn.26152.98233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Botia Paniagua, Enrique. "Neurologia@net." Revista de Neurología 26, no. 153 (1998): 846. http://dx.doi.org/10.33588/rn.26153.98234.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bandini, Micha. "The Net." Performance Research 26, no. 6 (2021): 34–35. http://dx.doi.org/10.1080/13528165.2021.2059181.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Kester, Grant. "Net Profits." Afterimage 22, no. 7-8 (1995): 8–10. http://dx.doi.org/10.1525/aft.1995.22.7-8.8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Xie, Liuyue, Tinglin Duan, and Kenji Shimada. "SAGA-net." ACM SIGAPP Applied Computing Review 22, no. 2 (2022): 21–33. http://dx.doi.org/10.1145/3558053.3558055.

Full text

Abstract:

In this paper, we propose a real-time shape-assisted graph attention neural network to perform local pointcloud repairment. The orderless pointclouds require an effective shape encoder to distill local and global geometric feature descriptors. Previous work has attempted to convert pointcloud representation into a voxelized shape or perform grid-transformations. While these approaches can subsequently allow common convolution operations on the structured data, they either pose additional computational cost or disrupt the local geometric information. We present SAGA-Net, an efficient graph atte

APA, Harvard, Vancouver, ISO, and other styles

46

Men, Yifang, Yuan Yao, Miaomiao Cui, Zhouhui Lian, and Xuansong Xie. "DCT-net." ACM Transactions on Graphics 41, no. 4 (2022): 1–9. http://dx.doi.org/10.1145/3528223.3530159.

Full text

Abstract:

This paper introduces DCT-Net, a novel image translation architecture for few-shot portrait stylization. Given limited style exemplars (~100), the new architecture can produce high-quality style transfer results with advanced ability to synthesize high-fidelity contents and strong generality to handle complicated scenes (e.g., occlusions and accessories). Moreover, it enables full-body image translation via one elegant evaluation network trained by partial observations (i.e., stylized heads). Few-shot learning based style transfer is challenging since the learned model can easily become overfi

APA, Harvard, Vancouver, ISO, and other styles

47

Vinay, A., Paras S. Khurana, T. B. Sudarshan, et al. "AFMB-Net." Tehnički glasnik 16, no. 4 (2022): 503–8. http://dx.doi.org/10.31803/tg-20220403080215.

Full text

Abstract:

With advances in deepfake generating technology, it is getting increasingly difficult to detect deepfakes. Deepfakes can be used for many malpractices such as blackmail, politics, social media, etc. These can lead to widespread misinformation and can be harmful to an individual or an institution’s reputation. It has become important to be able to identify deepfakes effectively, while there exist many machine learning techniques to identify them, these methods are not able to cope up with the rapidly improving GAN technology which is used to generate deepfakes. Our project aims to identify deep

APA, Harvard, Vancouver, ISO, and other styles

48

Feingold, Ken. "Net-Works." Leonardo 29, no. 5 (1996): 459. http://dx.doi.org/10.2307/1576410.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Feingold, Ken. "Net-Works." Leonardo 30, no. 5 (1997): 449. http://dx.doi.org/10.2307/1576503.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Pivec, Franci. "Net generacija." Organizacija znanja 13, no. 2 (2008): 61–63. http://dx.doi.org/10.3359/oz0802061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!